|
|||||
|
|
Response to erythropoiesis-stimulating agents in patients with WHO-defined myelodysplastic syndrome/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis (MDS/MPN-RS-T) |
|
| Authors: | Guadalupe Antelo Abhishek A. Mangaonkar Giacomo Coltro Ajinkya Buradkar Terra L. Lasho Christy Finke Ryan Carr Moritz Binder Naseema Gangat Aref Al-Kali Michelle A. Elliott Rebecca L. King Matthew Howard Megan E. Melody William Hogan Mark R Litzow Ayalew Tefferi Martin E. Fernandez-Zapico Rami Komrokji Mrinal M. Patnaik |
| Affiliation: | 1. Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA These authors contributed equally.;2. Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA;3. Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA;4. Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL, USA;5. Division of Oncology Research, Department of Medical Oncology, Mayo Clinic, Rochester, MN, USA |
| Abstract: | |
| Keywords: | MDS/MPN-RS-T myeloid leukaemia erythropoiesis stimulating agents ESA MDS-RS sideroblastic anaemia |